Bahman Akbari

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

International journal of genomics

Genesis (New York, N.Y. : 2000)

Journal of drug targeting

Genetic testing and molecular biomarkers

Kermanshah University of Medical Sciences

Tabriz University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kermanshah University of Medical Sciences Jun 05 2017

Iran

Assistant professor/ :: Medical biotechnology

Education History

Tabriz University of Medical Sciences Feb 04 2012 - Dec 13 2016

Iran

PHD :: faculty of advance medical sciences

Publications

Bahareh Rabbani, Mohadeseh Aghli Moghadam, Shiva Esmaeili, Amirhassan Rabbani, Bahman Akbari, Nejat Mahdieh
Pancreatitis as a Main Consequence of APOC2 -Related Hypertriglyceridemia: The Role of Nonsense and Frameshift Variants. International journal of genomics 2024 (2024)
Bahareh Rabbani, Mohadeseh Aghli Moghadam, Shiva Esmaeili, Amirhassan Rabbani, Bahman Akbari, Nejat Mahdieh
Pancreatitis as a Main Consequence of APOC2 -Related Hypertriglyceridemia: The Role of Nonsense and Frameshift Variants. International journal of genomics 2024 (2024)
Ali Alizadeh Severi, Bahman Akbari
CRISPR-Cas9 delivery strategies and applications: Review and update. Genesis (New York, N.Y. : 2000) 62 (3) (2024)
Ali Alizadeh Severi, Bahman Akbari
CRISPR-Cas9 delivery strategies and applications: Review and update. Genesis (New York, N.Y. : 2000) 62 (3) (2024)
Bahareh Rabbani, Mohadeseh Aghli Moghadam, Shiva Esmaeili, Amirhassan Rabbani, Bahman Akbari, Nejat Mahdieh
Pancreatitis as a Main Consequence of APOC2 -Related Hypertriglyceridemia: The Role of Nonsense and Frameshift Variants. International journal of genomics 2024 (2024)
Mohammad Abdolsamadi, Sharareh Rasouli, Ali Alizadeh Severi, Mohammad Reza Khirehgesh, Fatemeh Safari, Nejat Mahdieh, Habibolah Khazaie, Bijan Soleymani, Bahman Akbari
The Association Between the 5-Hydroxytryptamine Receptor 2A Gene Variants rs6311 and rs6313 and Obstructive Sleep Apnea in the Iranian Kurdish Population. Genetic testing and molecular biomarkers 28 (4) (2024)
Mohammad Abdolsamadi, Sharareh Rasouli, Ali Alizadeh Severi, Mohammad Reza Khirehgesh, Fatemeh Safari, Nejat Mahdieh, Habibolah Khazaie, Bijan Soleymani, Bahman Akbari
The Association Between the 5-Hydroxytryptamine Receptor 2A Gene Variants rs6311 and rs6313 and Obstructive Sleep Apnea in the Iranian Kurdish Population. Genetic testing and molecular biomarkers 28 (4) (2024)
Ali Alizadeh Severi, Bahman Akbari
CRISPR-Cas9 delivery strategies and applications: Review and update. Genesis (New York, N.Y. : 2000) 62 (3) (2024)
Bahareh Rabbani, Mohadeseh Aghli Moghadam, Shiva Esmaeili, Amirhassan Rabbani, Bahman Akbari, Nejat Mahdieh
Pancreatitis as a Main Consequence of APOC2 -Related Hypertriglyceridemia: The Role of Nonsense and Frameshift Variants. International journal of genomics 2024 (2024)
Mohammad Reza Khirehgesh, Jafar Sharifi, Fatemeh Safari, Bahman Akbari
Immunotoxins and nanobody-based immunotoxins: review and update. Journal of drug targeting 29 (8) (2021)
Jafar Sharifi, Mohammad Reza Khirehgesh, Bahman Akbari, Bijan Soleymani, Kamran Mansouri
Paper Title "Hu7CG2: A Novel Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Biparatopic Nanobody". Molecular biotechnology 63 (6) (2021)
Jafar Sharifi, Mohammad Reza Khirehgesh, Fatemeh Safari, Bahman Akbari
EGFR and anti-EGFR nanobodies: review and update. Journal of drug targeting 29 (4) (2020)

Bahman Akbari.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bahman Akbari